 TÜBINGEN, GERMANY and BOSTON, MA ACCESSWIRE April 22, 2022 CureVac N.V. NASDAQ:CVAC, a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid mRNA, will report financial results, and provide business updates for the fourth quarter and full-year 2021 on Thursday, April 28, 2022. 